SCOPUS 정보 검색 플랫폼

The Lancet

Volumn 385, Issue 9977, 2015, Pages 1507-1508

Prostate cancer screening in Europe - Authors' reply

(6) Schröder, Fritz a Hugosson, Jonas b Carlsson, Sigrid b Moss, Sue c Roobol, Monique d Auvinen, Anssi e

a ERASMUS MEDICAL CENTER (Netherlands)

b UNIVERSITY OF GOTHENBURG (Sweden)

c MEMORIAL SLOAN KETTERING CANCER CENTER (United States)

d QUEEN MARY UNIVERSITY OF LONDON (United Kingdom)

e TAMPERE UNIVERSITY OF TECHNOLOGY (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANDROGEN DEPRIVATION THERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; FOLLOW UP; HEALTH CARE SYSTEM; HUMAN; INTERMEDIATE RISK POPULATION; LETTER; LOW RISK POPULATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; MALE; MORTALITY; PROSTATIC NEOPLASMS;

HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 84928400389 PISSN: 01406736 EISSN: 1474547X Source Type: Journal
DOI: 10.1016/S0140-6736(15)60749-8 Document Type: Letter

Times cited : (4)

References (6)

1
- 84919871373
- Screening and prostate cancer mortality: Results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
- FH Schröder, J Hugosson, MJ Roobol et al. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up Lancet 384 2014 2027 2035
- (2014) Lancet , vol.384 , pp. 2027-2035
- Schröder, F.H.¹ Hugosson, J.² Roobol, M.J.³

2
- 9144236203
- Determining the cause of death in randomized screening trial(s) for prostate cancer
- HJ De Koning, J Blom, JW Merkelbach et al. Determining the cause of death in randomized screening trial(s) for prostate cancer BJU Int 92 2003 71 78
- (2003) BJU Int , vol.92 , pp. 71-78
- De Koning, H.J.¹ Blom, J.² Merkelbach, J.W.³

3
- 78049465045
- Blinded and uniform causes of death verification in cancer screening: A major influence on the outcome of a prostate cancer screening trial?
- SJ Otto, PJ van Leeuwen, JW Hoekstra et al. Blinded and uniform causes of death verification in cancer screening: a major influence on the outcome of a prostate cancer screening trial? Eur J Cancer 46 2010 3061 3067
- (2010) Eur J Cancer , vol.46 , pp. 3061-3067
- Otto, S.J.¹ Van Leeuwen, P.J.² Hoekstra, J.W.³

4
- 84905912396
- A different method of evaluation of the ERSPC trial confirms that prostate-specific antigen testing has a significant impact on prostate cancer mortality
- M Zappa, D Puliti, J Hugosson et al. A different method of evaluation of the ERSPC trial confirms that prostate-specific antigen testing has a significant impact on prostate cancer mortality Eur Urol 66 2014 401 403
- (2014) Eur Urol , vol.66 , pp. 401-403
- Zappa, M.¹ Puliti, D.² Hugosson, J.³

5
- 84905158869
- RE: Prostate-specific antigen screening trials and prostate cancer deaths: The androgen deprivation connection
- published online April 26
- S Carlsson, MJ Roobol, FH Schröder, J Hugosson, A Auvinen RE: Prostate-specific antigen screening trials and prostate cancer deaths: the androgen deprivation connection J Natl Cancer Inst 2014 10.1093/jnci/dju079 published online April 26.
- (2014) J Natl Cancer Inst
- Carlsson, S.¹ Roobol, M.J.² Schröder, F.H.³ Hugosson, J.⁴ Auvinen, A.⁵

6
- 77951228961
- The effect of study arm on prostate cancer treatment in the large screening trial ERSPC
- T Wolters, MJ Roobol, EW Steyerberg et al. The effect of study arm on prostate cancer treatment in the large screening trial ERSPC Int J Cancer 126 2010 2387 2393
- (2010) Int J Cancer , vol.126 , pp. 2387-2393
- Wolters, T.¹ Roobol, M.J.² Steyerberg, E.W.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.